YiFeng Lu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

YiFeng Lu

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Neuropharmacology|March 19, 2017

[<sup>3</sup>H]BMT-046091 a potent and selective radioligand to determine AAK1 distribution and target engagementJustin V Louis, Yifeng Lu, Rick Pieschl, et al.

Molecular Therapy. Nucleic Acids|September 12, 2022

Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathiesAmy Easton, Marianne L Jensen, Congwei Wang, et al.

The Journal of Pharmacology and Experimental Therapeutics|July 15, 2016

Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic PainWalter Kostich, Brian D Hamman, Yu-Wen Li, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Neuropharmacology|March 19, 2017

[<sup>3</sup>H]BMT-046091 a potent and selective radioligand to determine AAK1 distribution and target engagementJustin V Louis, Yifeng Lu, Rick Pieschl, et al.

Molecular Therapy. Nucleic Acids|September 12, 2022

Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathiesAmy Easton, Marianne L Jensen, Congwei Wang, et al.

The Journal of Pharmacology and Experimental Therapeutics|July 15, 2016

Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic PainWalter Kostich, Brian D Hamman, Yu-Wen Li, et al.

Pageof 5